# RBB Bancorp: overview

RBB · Nasdaq · CIK 1499422 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rbb.md) · [Financials](/companies/rbb/financials.md) · [Filings](/companies/rbb/filings.md) · [Insiders](/companies/rbb/insiders.md)

Latest reported revenue: [$1.1m](/filings/0001437749-26-026563.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 7, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001437749-26-026563).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1.3](/filings/0001437749-25-033871.md) | [1.1](/filings/0001437749-25-016170.md) | [1.1](/filings/0001437749-26-015865.md) | [1.4](/filings/0001437749-26-026563.md) | [1.3](/filings/0001437749-25-033871.md) | [1.3](/filings/0001437749-26-015865.md) | [2.1](/filings/0001437749-26-026563.md) | [1.1](/filings/0001437749-26-026563.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [551.1%](/filings/0001437749-25-033871.md) | [397.6%](/filings/0001437749-25-016170.md) | [205.8%](/filings/0001437749-26-015865.md) | [675.8%](/filings/0001437749-26-026563.md) | [766.5%](/filings/0001437749-25-033871.md) | [754.4%](/filings/0001437749-26-015865.md) | [545.1%](/filings/0001437749-26-026563.md) | [963.9%](/filings/0001437749-26-026563.md) |
| Diluted EPS | $ per share | [0.39](/filings/0001437749-25-033871.md) | [0.25](/filings/0001437749-25-016170.md) | [0.13](/filings/0001437749-26-015865.md) | [0.52](/filings/0001437749-26-026563.md) | [0.59](/filings/0001437749-25-033871.md) | [0.59](/filings/0001437749-26-015865.md) | [0.66](/filings/0001437749-26-026563.md) | [0.59](/filings/0001437749-26-026563.md) |
| Free cash flow | $m | [24.2 d](/filings/0001437749-25-033871.md) | [17.2 d](/filings/0001437749-26-007387.md) | [7.6](/filings/0001437749-26-015865.md) | [21.6 d](/filings/0001437749-26-026563.md) | [1.8 d](/filings/0001437749-25-033871.md) | [11.7 d](/filings/0001437749-26-007387.md) | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:ProfitLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [7.1](/filings/0001437749-24-007474.md) | [5.6](/filings/0001437749-25-008002.md) | [5.3](/filings/0001437749-26-007387.md) | [5.3](/filings/0001437749-26-007387.md) | [5.2](/filings/0001437749-26-007387.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [805.2%](/filings/0001437749-24-007474.md) | [1153.0%](/filings/0001437749-25-008002.md) | [797.9%](/filings/0001437749-26-007387.md) | [503.8%](/filings/0001437749-26-007387.md) | [618.3%](/filings/0001437749-26-007387.md) |
| Diluted EPS | $ per share | [2.86](/filings/0001437749-24-007474.md) | [3.33](/filings/0001437749-25-008002.md) | [2.24](/filings/0001437749-26-007387.md) | [1.47](/filings/0001437749-26-007387.md) | [1.83](/filings/0001437749-26-007387.md) |
| Free cash flow | $m | [200](/filings/0001437749-24-007474.md) | [91.7](/filings/0001437749-25-008002.md) | [50.6](/filings/0001437749-26-007387.md) | [57.7](/filings/0001437749-26-007387.md) | [42.6](/filings/0001437749-26-007387.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:ProfitLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/rbb/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $35.4m | 1,292,135 |  | Added +150,787 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $24.7m | 902,290 |  | Added +72,076 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $17.6m | 641,304 |  | Reduced −18,721 |
| [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $14.7m | 536,436 |  | Added +68,758 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $10.2m | 370,553 |  | Added +23,223 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $9.3m | 337,621 |  | Added +12,799 |
| [Hillsdale Investment Management Inc.](/funds/1368465.md) | 2026-06-30 | $9.0m | 327,169 |  | Added +105,769 |
| [ARROWSTREET CAPITAL, LIMITED PARTNERSHIP](/funds/1164508.md) | 2026-06-30 | $6.1m | 223,877 |  | Added +24,142 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $5.7m | 206,553 |  | Added +73,971 |
| [Qube Research & Technologies Ltd](/funds/1729829.md) | 2026-06-30 | $5.4m | 195,579 |  | Added +136,611 |

## Recent filings

[All 802 filings](/companies/rbb/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-19 | 16:47 ET | [8-K](/filings/0001628280-26-066329.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-066329 |
| 2026-09-08 | 18:38 ET | [8-K](/filings/0001437749-26-029729.md) | 5.02 Departure or appointment of officers or directors | 0001437749-26-029729 |
| 2026-08-07 | 15:45 ET | [10-Q](/filings/0001437749-26-026563.md) | Quarterly report, period 2026-06-30 | 0001437749-26-026563 |
| 2026-07-20 | 16:29 ET | [8-K](/filings/0001437749-26-023874.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-023874 |
| 2026-06-15 | 12:37 ET | [8-K](/filings/0001437749-26-020620.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-020620 |
| 2026-05-22 | 13:02 ET | [8-K](/filings/0001437749-26-018208.md) | 5.07 Shareholder vote results | 0001437749-26-018208 |
| 2026-05-08 | 15:24 ET | [10-Q](/filings/0001437749-26-015865.md) | Quarterly report, period 2026-03-31 | 0001437749-26-015865 |
| 2026-04-20 | 16:40 ET | [8-K](/filings/0001437749-26-012840.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-012840 |
| 2026-04-10 | 13:30 ET | [DEF 14A](/filings/0001437749-26-011980.md) | Proxy statement, period 2026-05-21 | 0001437749-26-011980 |
| 2026-04-06 | 16:19 ET | [8-K](/filings/0001437749-26-011393.md) | 5.02 Departure or appointment of officers or directors | 0001437749-26-011393 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001437749-26-007387.md), filed Mar 9, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1499422
- Tickers: RBB
- Exchange: Nasdaq
- SIC code: 6022 State Commercial Banks
- State of incorporation: CA
- Filer category: Accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 19:51 ET. No prices; not investment advice.